Biomimetic Therapeutics, Inc. (BMTI) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	15.49M
Investments - short term	28.77M
Receivables - trade	347.69K
Receivables - other	263.53K
Inventory	4.06M
Prepaid expenses	568.35K
Total current assets	49.5M
Investments - long term
Prepaid expenses - long term	1.29K
Property and equipment, net	4.37M
Capitalized patent license fees, net	2.66M
Deposits	385K
Total assets	57.09M
Accounts payable	830.38K
Accrued payroll, employee benefits and payroll taxes	2.03M
Other accrued expenses	344.17K
Current portion of capital lease obligations	88.74K
Deferred revenue	971.19K
Total current liabilities	4.26M
Accrued rent - related party	585.17K
Capital lease obligations	67.64K
Deferred revenue	12.88M
Total liabilities	17.8M
Preferred stock, $0.001 par value; 15,000,000 shares authorized; no shares issued and outstanding as of June 30, 2011 and December 31, 2010	0
Common stock, $0.001 par value; 100,000,000 shares authorized; 28,001,018 shares issued and outstanding as of June 30, 2011; 27,925,984 shares issued and outstanding as of December 31, 2010	28.23K
Additional paid-in capital	217.04M
Accumulated other comprehensive income (loss)	9.85K
Accumulated deficit	-177.78M
Total stockholders' equity	39.29M
Total liabilities and stockholders' equity	57.09M

Entities mentioned with BMTI

View All Entities